-
Something wrong with this record ?
Evaluation of the effects of N-acetylcysteine on serum glucose, lipid profile, and body weight in rats with fructose-induced metabolic syndrome
Auss Z. Yahya, Ghada A. Taqa, Muhammad A. Alkataan
Language English Country Czech Republic
Digital library NLK
Source
NLK
ROAD: Directory of Open Access Scholarly Resources
from 2011
- MeSH
- Acetylcysteine * administration & dosage pharmacology MeSH
- Fructose administration & dosage adverse effects MeSH
- Blood Glucose drug effects MeSH
- Rats MeSH
- Metabolic Syndrome * chemically induced drug therapy blood MeSH
- Disease Models, Animal MeSH
- Body Weight drug effects MeSH
- Treatment Outcome MeSH
- Check Tag
- Rats MeSH
- Male MeSH
Background: Overconsumption of fructose may cause metabolic syndrome (MetS). MetS pathogenesis is caused by oxidative stress, cellular malfunction, and systemic inflammation caused by hereditary and environmental factors. N-acetylcysteine (NAC) has become associated with the phrase "antioxidant." Most researchers use and test NAC with the goal of preventing or reducing oxidative stress.Aim: To determine the positive effects of NAC on blood glucose, lipid profile, and body weight in fructose-induced metabolic syndrome in albino rats.Materials and Methods: Forty male albino rats, 10-12 weeks old, were haphazardly divided into five groups of identical size. Group I (negative control) received tap water for 12 weeks. Group II (positive control) received a 60% w/w fructose solution (60% FS) instead of tap water for 12 weeks. Group III (NAC) received tap water and an intra-peritoneal (IP) injection of NAC (150 mg/kg/day) for 12 weeks. Group IV (protection) co-administered 60% FS orally and NAC IP injection (150 mg/kg/day) for 12 weeks. Group V (treatment) received 60% FS for 8 weeks followed by 4 weeks of drinking tap water with NAC IP injection (150 mg/kg/day). Blood samples were taken at weeks 0, 8, and 12 and were tested for serum glucose and lipid profile. All animals of each group were weighted at weeks 0, 8 and 12 of the study.Results: Concerning serum glucose, group II showed increased glycaemia at week 8 and further elevation during week 12. Group III displayed normal glycaemia at weeks 8 and 12. In group IV, glycaemia showed elevation at week 8 followed by almost complete restoration at week 12. In group V, there was an increased glycaemia at week 8 followed by a partial restoration at week 12. Regarding lipid profile parameters, group II demonstrated a deterioration during week 8 and more worsening during week 12. There were no significant changes in group III's parameters during weeks 8 and 12. Group IV displayed a worsening in lipid profile during week 8 followed by a nearly complete improvement during week 12. During week 8, group V deteriorated, followed by a partial recovery during week 12. Concerning body weight, group II showed a weight gain at week 8 and further elevation during week 12. Group III displayed normal glycaemia at weeks 8 and 12. In group IV, glycaemia showed elevation at week 8 followed by almost complete restoration at week 12. In group V, there was an increased glycaemia at week 8 followed by a partial restoration at week 12. At week 8, there was a significant elevation in body weights in groups II and V compared to group I. Moreover, a significant reduction in body weight was recorded in group IV compared to group II during week 8. At week 12, a significant elevation in body weight was noticed in groups II and V compared to group I. Moreover, there was a significant reduction in body weight in group III compared to group I. On the other hand, there was a significant fall in body weight in groups IV and V compared to group II during week 12.Conclusion: MetS was caused by a high-fructose diet, which has been shown to have a negative impact on serum glucose, lipid profiles, and body weight. Moreover, NAC has been shown to enhance these parameters in a time-dependent manner.
Department of Biochemistry College of Medicine University of Ninevah Mosul Iraq
Department of Dental Basic Sciences College of Dentistry University of Mosul Mosul Iraq
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23013697
- 003
- CZ-PrNML
- 005
- 20231110100344.0
- 007
- ta
- 008
- 230913s2023 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.31482/mmsl.2022.039 $2 doi
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Yahya, Auss Z. $u Ministry of Health, Ninevah Heath Directorate, Mosul, Iraq
- 245 10
- $a Evaluation of the effects of N-acetylcysteine on serum glucose, lipid profile, and body weight in rats with fructose-induced metabolic syndrome / $c Auss Z. Yahya, Ghada A. Taqa, Muhammad A. Alkataan
- 504 __
- $a Literatura
- 520 9_
- $a Background: Overconsumption of fructose may cause metabolic syndrome (MetS). MetS pathogenesis is caused by oxidative stress, cellular malfunction, and systemic inflammation caused by hereditary and environmental factors. N-acetylcysteine (NAC) has become associated with the phrase "antioxidant." Most researchers use and test NAC with the goal of preventing or reducing oxidative stress.Aim: To determine the positive effects of NAC on blood glucose, lipid profile, and body weight in fructose-induced metabolic syndrome in albino rats.Materials and Methods: Forty male albino rats, 10-12 weeks old, were haphazardly divided into five groups of identical size. Group I (negative control) received tap water for 12 weeks. Group II (positive control) received a 60% w/w fructose solution (60% FS) instead of tap water for 12 weeks. Group III (NAC) received tap water and an intra-peritoneal (IP) injection of NAC (150 mg/kg/day) for 12 weeks. Group IV (protection) co-administered 60% FS orally and NAC IP injection (150 mg/kg/day) for 12 weeks. Group V (treatment) received 60% FS for 8 weeks followed by 4 weeks of drinking tap water with NAC IP injection (150 mg/kg/day). Blood samples were taken at weeks 0, 8, and 12 and were tested for serum glucose and lipid profile. All animals of each group were weighted at weeks 0, 8 and 12 of the study.Results: Concerning serum glucose, group II showed increased glycaemia at week 8 and further elevation during week 12. Group III displayed normal glycaemia at weeks 8 and 12. In group IV, glycaemia showed elevation at week 8 followed by almost complete restoration at week 12. In group V, there was an increased glycaemia at week 8 followed by a partial restoration at week 12. Regarding lipid profile parameters, group II demonstrated a deterioration during week 8 and more worsening during week 12. There were no significant changes in group III's parameters during weeks 8 and 12. Group IV displayed a worsening in lipid profile during week 8 followed by a nearly complete improvement during week 12. During week 8, group V deteriorated, followed by a partial recovery during week 12. Concerning body weight, group II showed a weight gain at week 8 and further elevation during week 12. Group III displayed normal glycaemia at weeks 8 and 12. In group IV, glycaemia showed elevation at week 8 followed by almost complete restoration at week 12. In group V, there was an increased glycaemia at week 8 followed by a partial restoration at week 12. At week 8, there was a significant elevation in body weights in groups II and V compared to group I. Moreover, a significant reduction in body weight was recorded in group IV compared to group II during week 8. At week 12, a significant elevation in body weight was noticed in groups II and V compared to group I. Moreover, there was a significant reduction in body weight in group III compared to group I. On the other hand, there was a significant fall in body weight in groups IV and V compared to group II during week 12.Conclusion: MetS was caused by a high-fructose diet, which has been shown to have a negative impact on serum glucose, lipid profiles, and body weight. Moreover, NAC has been shown to enhance these parameters in a time-dependent manner.
- 650 17
- $a acetylcystein $x aplikace a dávkování $x farmakologie $7 D000111 $2 czmesh
- 650 _7
- $a krevní glukóza $x účinky léků $7 D001786 $2 czmesh
- 650 _7
- $a tělesná hmotnost $x účinky léků $7 D001835 $2 czmesh
- 650 17
- $a metabolický syndrom $x chemicky indukované $x farmakoterapie $x krev $7 D024821 $2 czmesh
- 650 _7
- $a fruktosa $x aplikace a dávkování $x škodlivé účinky $7 D005632 $2 czmesh
- 650 _7
- $a modely nemocí na zvířatech $7 D004195 $2 czmesh
- 650 _7
- $a krysa rodu Rattus $7 D051381 $2 czmesh
- 650 _7
- $a výsledek terapie $7 D016896 $2 czmesh
- 650 _7
- $a mužské pohlaví $7 D008297 $2 czmesh
- 700 1_
- $a Taqa, Ghada A. $u Department of Dental Basic Sciences, College of Dentistry, University of Mosul, Mosul, Iraq
- 700 1_
- $a Alkataan, Muhammad A. $u Department of Biochemistry, College of Medicine, University of Ninevah, Mosul, Iraq
- 773 0_
- $t Vojenské zdravotnické listy $x 0372-7025 $g Roč. 92, č. 3 (2023), s. 194-207 $w MED00011116
- 856 41
- $u https://mmsl.cz/artkey/mms-202303-0001_evaluation-of-the-effects-of-n-acetylcysteine-on-serum-glucose-lipid-profile-and-body-weight-in-rats-with-fru.php $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 3 $c 1073 $y p $z 0
- 990 __
- $a 20230905 $b ABA008
- 991 __
- $a 20231110100337 $b ABA008
- 999 __
- $a ok $b bmc $g 1983179 $s 1200007
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2023 $b 92 $c 3 $d 194-207 $e 20230901 $i 0372-7025 $m Vojenské zdravotnické listy $x MED00011116
- LZP __
- $c NLK189 $d 20231102 $b NLK111 $a Actavia-MED00011116-20230905